11-2 Expression in Different Levels of Celiac Disease Patients
Keywords:
IL-2, CD, qPCR, Gluten and Relapsed Cases.Abstract
Celiac disease (CD) is an autoimmune gastrointestinal ailment brought on by the ingestion of peptides found in wheat, rye, barley, and potentially oats in people who are genetically predisposed to developing the disease. Gluten, the cohesive protein mass generated by washing wheat dough to remove starch and other water-soluble components, has been labelled as dangerous proteins. Celiac disease is poorly known, including its method of presentation and immune response mechanism. To better understand the immunological response generated by celiac disease, this study analysed the demographic and clinical characteristics of 200 patients with whole blood and serum from the disease. ELIZA and qPCR were also used to measure the amount of IL-2 in the gene and serum at different stages of disease. The finding shows that IL-2 is an important part of the immune response at different stages of disease. The data showed that the titters of people with a new disease were much higher than those of healthy people. However, the titters of healthy people didn’t change when they were treated or kept away from gluten. It seems that IL-2 may have a direct role with celiac disease not only at the first stage of diseases but also at relapsed cases.
Downloads
References
Rubin JE, Crowe SE. Celiac disease. Annals of internal medicine.
;172(l):ITCl-ITC16.
Lebwohl B, Rubio-Tapia A. Epidemiology, presentation, and
diagnosis of celiac disease. Gastroenterology. 2021;160(1):63-75.
Ramirez-Sanchez AD, Tan IL, Gonera-de Jong B, Visschedijk MC,
Jonkers I, Withoff S. Molecular biomarkers for celiac disease: Past, present and future. International Journal of Molecular Sciences.
;21(22):8528.
Hearn NL, Chiu CL, Lind JM. Comparison of DNA methylation
profiles from saliva in Coeliac disease and non-coeliac disease
individuals. BMC Medical Genomics. 2020;13:1-11.
Shahriari M, Honar N, Yousefi A, Javaherizadeh H. Association of
potential celiac disease and refractory iron deficiency anemia in
children and adolescents. Arquivos de gastroenterologia.
;55:78-81.
Mohammadibakhsh R, Sohrabi R, Salemi M, Mirghaed MT,
Behzadifar M. Celiac disease in Iran: a systematic review and meta¬
analysis. Electronic physician. 2017;9(3):3883.
Molder A, Balaban DV, Jinga M, Molder C-C. Current evidence on
computer-aided diagnosis of celiac disease: Systematic review.
Frontiers in Pharmacology. 2020;11:341.
Iversen R, Sollid LM. The immunobiology and pathogenesis of
celiac disease. Annual Review of Pathology: Mechanisms of Disease.
;18:47-70.
Svigelj R, Zuliani I, Grazioli C, Dossi N, Toniolo R. An effective
label-free electrochemical aptasensor based on gold nanoparticles
for gluten detection. Nanomaterials. 2022;12(6):987.
Masaebi F, Looha MA, Rostami-Nejad M, Pourhoseingholi MA,
Mohseni N, Samasca G, et al. The predictive value of serum
cytokines for distinguishing celiac disease from non-celiac gluten
sensitivity and healthy subjects. Iranian Biomedical Journal.
;24(6):340.
Alkalay MJ. Update on celiac disease. Current opinion in pediatrics.
;32(5):654-60.
Bokhari HA, Shaik NA, Banaganapalli B, Nasser KK, Ageel HI, Al
Shamrani AS, et al. Whole exome sequencing of a Saudi family and
systems biology analysis identifies CPED1 as a putative causative
gene to Celiac Disease. Saudi Journal of Biological Sciences.
;27(6):1494-502.
Comino I, Segura V, Ortigosa L, Espin B, Castillejo G, Garrote JA,
et al. Prospective longitudinal study: use of faecal gluten
immunogenic peptides to monitor children diagnosed with coeliac
disease during transition to a gluten free diet. Alimentary
Pharmacology & Therapeutics. 2019;49(12):1484-92.
Lebwohl B, Sanders DS, Green PH. Coeliac disease. The Lancet.
;391(10115):70-81.
Van Kalleveen MW, de Meij T, Plotz FB. Clinical spectrum of
paediatric coeliac disease: a 10-year single-centre experience.
European Journal of Pediatrics. 2018;177:593-602.
Goel G, Daveson A, Hooi C, Tye-Din J, Wang S, Szymczak E, et al.
Serum cytokines elevated during gluten-mediated cytokine release
in coeliac disease. Clinical & Experimental Immunology.
;199(l):68-78.
Tye-Din JA, Skodje GI, Sarna VK, Dzuris JL, Russell AK, Goel G, et
al. Cytokine release after gluten ingestion differentiates coeliac
disease from self-reported gluten sensitivity. United European
gastroenterology journal. 2020;8(1):108-18.
McAllister CS, Kagnoff MF, editors. The immunopathogenesis of celiac disease reveals possible therapies beyond the gluten-free diet. Seminars in immunopathology; 2012: Springer.
Downloads
Published
Issue
Section
License
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
